DNA binding and cleaving activity of the new cleft molecule N,N'-Bis(guanidinoethyl)-2,6-pyridinedicarboxamide in the absence or in the presence of copper(II)

Bioconjugate Chemistry
Ying ShaoGuo-Yuan Lu

Abstract

Novel cleft molecule pyridine-2,6-dicarboxamide appending two guanidinoethyl group side arms (Gua) was synthesized. The interactions of the cleft molecule in the absence of copper(II) (Gua) or in the presence of copper(II) (Cu2+-Gua) with calf thymus DNA were studied by fluorescence and CD spectroscopy. The results indicate that the DNA binding affinity of Cu2+-Gua is stronger than that of Gua, and the binding constants of Cu2+-Gua and Gua are 1.61 x 10(6) M(-1) and 2.86 x 10(5) M(-1), respectively. Agarose gel electrophoresis was used to assess the plasmid pUC 19 DNA cleavage activities in the presence of Gua and Cu2+-Gua. Kinetic data of DNA cleavage promoted by Cu2+-Gua under physiological conditions fit a saturation kinetic profile with k(max) of 0.0173 +/- 0.0011 h(-1), which gave a aproximately 10(6)-fold rate acceleration over uncatalyzed supercoiled DNA, while the catalyst concentration is lower than 0.0625 mM. The hydrolysis pathway was proposed as the possible mechanism for DNA cleavage promoted by Cu2+-Gua. The acceleration is due to efficient cooperative catalysis of the copper cation center and the functional groups (bis(guanidinium) groups).

References

Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·F A CottonM J Legg
Mar 6, 1987·Science·F H Westheimer
Oct 15, 1996·European Journal of Biochemistry·P FriedhoffA Pingoud
Jun 1, 1997·Bioorganic & Medicinal Chemistry·D M PerreaultE V Anslyn
Jul 18, 2001·Journal of the American Chemical Society·A T AbrahamS M Hecht
Oct 25, 2001·The Journal of Organic Chemistry·Helmut H. Zepik, Steven A. Benner
Oct 30, 2001·The Journal of Organic Chemistry·B R LintonA D Hamilton
Dec 12, 2001·Current Opinion in Chemical Biology·J A Cowan
Dec 26, 2001·Chemical Reviews·M W Peczuh, A D Hamilton
Dec 26, 2001·Chemical Reviews·K E ErkkilaJ K Barton
Feb 19, 2002·Chemical Reviews·Wendy Knapp Pogozelski, Thomas D. Tullius
Feb 19, 2002·Chemical Reviews·Richard M. Burger
Feb 19, 2002·Chemical Reviews·Scott R. Rajski, Robert M. Williams
Aug 5, 1997·Chemical Reviews·Franz P. Schmidtchen, Michael Berger
Jul 18, 2002·Journal of Inorganic Biochemistry·Jie LiuLiangnian Ji
Aug 9, 2002·Journal of Medicinal Chemistry·Jonathan B RothbardPaul A Wender
Mar 18, 2003·Bioorganic & Medicinal Chemistry Letters·Sang-sup JewHyeung-geun Park
Nov 25, 2003·Inorganic Chemistry·Lei ZhuJames W Canary
Dec 4, 2003·Chemical Communications : Chem Comm·Meng-Yin YangJanet R Morrow
Apr 6, 2004·Current Opinion in Chemical Biology·Janet R Morrow, Olga Iranzo
Jul 15, 2004·Dalton Transactions : an International Journal of Inorganic Chemistry·Srecko I KirinNils Metzler-Nolte
Jul 22, 2004·Journal of the American Chemical Society·Carsten Schmuck, Lars Geiger
Aug 12, 2004·Journal of the American Chemical Society·Anna M PiatekEric V Anslyn
Sep 24, 2004·Dalton Transactions : an International Journal of Inorganic Chemistry·Tarkeshwar GuptaAkhil R Chakravarty
Nov 18, 2004·Bioconjugate Chemistry·Todd M CorneillieClaude F Meares
Feb 3, 2005·Chemistry : a European Journal·Clemens Wagner, Hans-Achim Wagenknecht
Feb 11, 2005·Dalton Transactions : an International Journal of Inorganic Chemistry·Konstantina KaridiJan Reedijk
Feb 17, 2005·Journal of the American Chemical Society·Ute SchefferMichael W Göbel
Mar 29, 2005·Inorganic Chemistry·Claudia SissiUmberto Tonellato
Jun 9, 2005·Journal of the American Chemical Society·Yan Jin, J A Cowan
Jul 29, 2005·Nucleic Acids Research·Kristie D GoodwinMillie M Georgiadis

❮ Previous
Next ❯

Citations

Sep 18, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dominic McBrayer, Sean M Kerwin
Apr 16, 2013·Biochemical and Biophysical Research Communications·Liang XuKeliang Liu
Jan 23, 2014·European Journal of Medicinal Chemistry·Antonio RescifinaAntonino Corsaro
Mar 18, 2015·Organic & Biomolecular Chemistry·Chunying MaRenzhong Qiao
May 12, 2011·Chemistry & Biodiversity·Yu ZhangXiao-Qi Yu
Aug 5, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Maoqun TianElke Brötz
Sep 26, 2012·Organic & Biomolecular Chemistry·Li WeiGuo-Yuan Lu
Dec 4, 2019·Dalton Transactions : an International Journal of Inorganic Chemistry·Ming LiuJing-Yuan Xu
Apr 19, 2011·Chembiochem : a European Journal of Chemical Biology·Stefan UllrichMichael W Göbel
Apr 30, 2013·Dalton Transactions : an International Journal of Inorganic Chemistry·Nathalie BerthetFabrice Thomas
Aug 19, 2010·Bioconjugate Chemistry·Shadad AlkhaderEylon Yavin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.